- Bevorzugter Name
- Rhodilunancin A
- IUPAC
- (1R,2R)-2-Ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(dimethylamino)-4-O-[(2S,5S,6S)-5-{[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy}-6-methyloxan-2-yl]-alpha-L-lyxo-hexopyranoside
- Englischer Name
- rhodilunancin A
- Summenformel
- C40H53NO13
- Molmasse
- 755.86
Namen und Synonyme
rhodilunancin A(9R,10R)-10-[(2S,4S,5S,6S)-4-(dimethylamino)-5-[(2S,5S,6S)-5-[(2S,5S,6S)-5-hydroxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-6-methyloxan-2-yl]oxy-9-ethyl-4,6,9,11-tetrahydroxy-8,10-dihydro-7H-tetracene-5,12-dione5,12-Naphthacenedione, 8-ethyl-7,8,9,10-tetrahydro-1,6,8,11-tetrahydroxy-7-[[2,3,6-trideoxy-3-(dimethylamino)-4-O-[(2S,5S,6S)-tetrahydro-6-methyl-5-[[(2S,5S,6S)-tetrahydro-5-hydroxy-6-methyl-2H-pyran-2-yl]oxy]-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]oxy]-, (7R,8R)-
Datenbank-Bezeichner
- PubChem CID
- 126042
- DTXSID
DTXSID70242399- ChEBI
CHEBI:209718- Nikkaji
- J92.040A